- Shahzad G. Raja, BSc, MBBS (Hons.), MRCS, FRCS(C-Th)
- Department of Cardiac Surgery, Harefield Hospital, London, United Kingdom.
Website | E-mail
Special Issue Introduction
Myocardial surgical revascularization, universally known as coronary artery bypass grafting (CABG), is regarded as the standard of care for treatment of multivessel coronary artery disease including left main stem stenosis. While very little changed over the first 50 years in terms of fundamental technique, the outcomes continued to improve with focus shifting away from peri-operative mortality to reducing the invasiveness of the procedure and associated morbidity. The last decade has seen a marked rise in percutaneous coronary interventions (PCI) particularly the use of drug-eluting stents for treatment of coronary artery disease. Expanding indications of PCI with encouraging results have resulted in a simultaneous drive to develop new surgical strategies to compete with the less invasive nature of PCI without compromising the outcomes of CABG. A variety of innovative techniques including minimally invasive multivessel CABG, anaortic total arterial off-pump CABG as well as quality improvement initiatives such as fractional flow reserve-guided CABG, epiaortic scanning, intraoperative assessment of graft flow and adherence to rigorous secondary prevention have emerged in the last decade with the potential to make surgical myocardial revascularization less invasive without jeopardising the outcomes. This special issue of Vessel Plus focuses on the “New Prospects in Myocardial Surgical Revascularization”. It is anticipated that the state-of-the-art contributions from international experts in this special issue will not only enhance the quality and scholarly impact of this special issue but also influence the existing clinical practice of myocardial surgical revascularization.
KeywordsAnaortic off-pump coronary artery bypass grafting, coronary artery bypass grafting, epiaortic scanning, minimally invasive multivessel coronary artery bypass grafting, secondary prevention, surgical myocardial revascularization
Submission Deadline30 Nov 2020